NVDA vs SSYS

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

Stratasys exhibits severe operational weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating fundamentals. While the company maintains a strong balance sheet with very low debt (D/E 0.03) and high liquidity (Current Ratio 3.57), it is failing to translate this stability into profitability or growth. Revenue is contracting (-6.90% YoY) and the stock is in a long-term bearish trend, losing over 58% of its value over five years. The current valuation below book value (P/B 0.90) suggests a value play, but the lack of earnings growth makes it a likely value trap.